(Q48337077)

English

FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy

scientific article published on August 4, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy (English)

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Pierandrea De Iaco

1

object named as

Pierandrea De Iaco

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688446

17 June 2024

author name string

Alessandra Musto

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Luca Orazi

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Claudio Zamagni

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Marta Rosati

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Vincenzo Allegri

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Nicoletta Cacciari

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Adil Al-Nahhas

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Domenico Rubello

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Stefano Venturoli

10

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Stefano Fanti

11

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688446

17 June 2024

publication date

4 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

full work available at URL

https://api.elsevier.com/content/article/PII:S0720048X10003487?httpAccept=text/xml

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

https://api.elsevier.com/content/article/PII:S0720048X10003487?httpAccept=text/plain

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

European Journal of Radiology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

80

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

e98-103

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Estimates of the worldwide incidence of 25 major cancers in 1990.

1

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Neoadjuvant chemotherapy in ovarian cancer

3

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

4

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.

6

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity

7

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding

8

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Distant metastases in ovarian carcinoma.

9

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Epithelial ovarian cancer presenting initially with extraabdominal or intrahepatic metastases: a preliminary report of 25 cases and literature review

10

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score

11

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy

12

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

13

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.

14

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group

15

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

PET/CT today: system and its impact on cancer diagnosis

16

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Molecular imaging of cancer with positron emission tomography

17

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients

18

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

A combined PET/CT scanner: the path to true image fusion

19

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET.

20

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls

21

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer

22

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Management of peritoneal-surface malignancy: the surgeon's role

23

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

24

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.

26

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

28

1 reference

10.1016/J.EJRAD.2010.07.013

https://api.crossref.org/works/10.1016/J.EJRAD.2010.07.013

17 June 2024

Identifiers

10.1016/J.EJRAD.2010.07.013

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20688446

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48337077&oldid=2182089801"